Assembly Biosciences (ASMB) Share-based Compensation (2010 - 2026)

Assembly Biosciences' Share-based Compensation history runs 17 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• In Q1 2026, Share-based Compensation rose 56.74% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $5.1 million (up 64.27% YoY), while the FY2025 annual figure was $4.7 million, up 49.9% from the prior year.
• Share-based Compensation was $1.1 million for Q1 2026 at Assembly Biosciences, down from $1.5 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $2.0 million in Q4 2022 to a low of $712000.0 in Q1 2025.
• Historically, Share-based Compensation has averaged $1.2 million across 5 years, with a median of $1.1 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Share-based Compensation soared 604.55% in 2022, then plunged 59.73% in 2024.
• A 5-year view of Share-based Compensation shows it stood at $2.0 million in 2022, then sank by 52.36% to $959000.0 in 2023, then dropped by 21.69% to $751000.0 in 2024, then soared by 94.54% to $1.5 million in 2025, then dropped by 23.61% to $1.1 million in 2026.
• The last three Share-based Compensation figures came in at $1.1 million (Q1 2026), $1.5 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.